The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Home > Documents > Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 for transactions with shares of "Sopharma" AD as of 19 December 2024
Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 for transactions with shares of "Sopharma" AD as of 19 December 2024